Company / Revenue per Share
ATOSSA THERAPEUTICS, INC. Revenue per Share History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.00
FY2016
5-year range
$0.00 / $0.04
FY2012-FY2016
Trend
-50.6%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has declined for 3 consecutive years, from $0.04 in FY2013 to $0.00 in FY2016.
Based on SEC 10-K filings.
0.00 in FY2016 with a 3-year CAGR of -72.1%.
Declined from $0.03 to $0.00 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -72.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- ATOSSA THERAPEUTICS, INC.'s revenue per share has declined for 3 consecutive years.
- In FY2016, revenue per share decreased 50.6% year-over-year.
- Peak revenue per share was recorded in FY2013.
- Lowest revenue per share in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | $0.00 | -50.6% |
| FY2015 | $0.00 | -95.2% |
| FY2014 | $0.03 | -8.7% |
| FY2013 | $0.04 | +27889.1% |
| FY2012 | $0.00 | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026